Latest market price
213.79
-3.82-1.76%
IBBiShares Biotechnology ETF·NASDAQ
213.79-1.76%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 28, 2026497Definitive prospectus
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13GBeneficial ownership statement (passive)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13GBeneficial ownership statement (passive)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13GBeneficial ownership statement (passive)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)